These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18984632)

  • 1. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States.
    McLellan AT; Skipper GS; Campbell M; DuPont RL
    BMJ; 2008 Nov; 337():a2038. PubMed ID: 18984632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis for Emergency Physician with substance abuse recovery: 5-year outcome study.
    Rose JS; Campbell M; Skipper G
    West J Emerg Med; 2014 Feb; 15(1):20-5. PubMed ID: 24696748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis for the recovery of surgeons from chemical dependency: a 5-year outcome study.
    Buhl A; Oreskovich MR; Meredith CW; Campbell MD; Dupont RL
    Arch Surg; 2011 Nov; 146(11):1286-91. PubMed ID: 22106321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anesthesiologists with substance use disorders: a 5-year outcome study from 16 state physician health programs.
    Skipper GE; Campbell MD; Dupont RL
    Anesth Analg; 2009 Sep; 109(3):891-6. PubMed ID: 19690263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatrists with substance use disorders: positive treatment outcomes from physician health programs.
    Yellowlees PM; Campbell MD; Rose JS; Burke Parish M; Ferrer D; Scher LM; Skipper GE; DuPont RL
    Psychiatr Serv; 2014 Dec; 65(12):1492-5. PubMed ID: 25270988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family Medicine Physicians With Substance Use Disorder: A 5-year Outcome Study.
    Rose JS; Campbell MD; Yellowlees P; Skipper GE; DuPont RL
    J Addict Med; 2017; 11(2):93-97. PubMed ID: 28067757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Physicians with Substance Use Disorders in State Physician Health Programs: A Narrative Review.
    Goldenberg M; Miotto K; Skipper GE; Sanford J
    J Psychoactive Drugs; 2020; 52(3):195-202. PubMed ID: 32156222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impaired Surgeon.
    Sudan R; Seymour K
    Surg Clin North Am; 2016 Feb; 96(1):89-93. PubMed ID: 26612022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes of doctors in a substance dependence monitoring programme in Canada: prospective descriptive study.
    Brewster JM; Kaufmann IM; Hutchison S; MacWilliam C
    BMJ; 2008 Nov; 337():a2098. PubMed ID: 18981018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of substance use among US physicians.
    Hughes PH; Brandenburg N; Baldwin DC; Storr CL; Williams KM; Anthony JC; Sheehan DV
    JAMA; 1992 May; 267(17):2333-9. PubMed ID: 1348789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Integrated Intervention for Dual Problems and Early Action Among Latino Immigrants With Co-occurring Mental Health and Substance Misuse Symptoms: A Randomized Clinical Trial.
    Alegría M; Falgas-Bague I; Collazos F; Carmona Camacho R; Lapatin Markle S; Wang Y; Baca-García E; Lê Cook B; Chavez LM; Fortuna L; Herrera L; Qureshi A; Ramos Z; González C; Aroca P; Albarracín García L; Cellerino L; Villar A; Ali N; Mueser KT; Shrout PE
    JAMA Netw Open; 2019 Jan; 2(1):e186927. PubMed ID: 30646205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How are addicted physicians treated? A national survey of Physician Health Programs.
    DuPont RL; McLellan AT; Carr G; Gendel M; Skipper GE
    J Subst Abuse Treat; 2009 Jul; 37(1):1-7. PubMed ID: 19482236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use and addiction among medical students, residents, and physicians.
    Flaherty JA; Richman JA
    Psychiatr Clin North Am; 1993 Mar; 16(1):189-97. PubMed ID: 8456044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating substance-use disorders among physicians.
    Herrington RE; Benzer DG; Jacobson GR; Hawkins MK
    JAMA; 1982 Apr; 247(16):2253-7. PubMed ID: 7069878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.
    Friedmann PD; Zhang Z; Hendrickson J; Stein MD; Gerstein DR
    J Gen Intern Med; 2003 Jan; 18(1):1-8. PubMed ID: 12534757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of physicians treated for alcoholism and drug dependence.
    Morse RM; Martin MA; Swenson WM; Niven RG
    JAMA; 1984 Feb; 251(6):743-6. PubMed ID: 6694277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Setting the standard for recovery: Physicians' Health Programs.
    DuPont RL; McLellan AT; White WL; Merlo LJ; Gold MS
    J Subst Abuse Treat; 2009 Mar; 36(2):159-71. PubMed ID: 19161896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician views regarding substance use-related participation in a state physician health program.
    Merlo LJ; Greene WM
    Am J Addict; 2010; 19(6):529-33. PubMed ID: 20958849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician health programmes and malpractice claims: reducing risk through monitoring.
    Brooks E; Gendel MH; Gundersen DC; Early SR; Schirrmacher R; Lembitz A; Shore JH
    Occup Med (Lond); 2013 Jun; 63(4):274-80. PubMed ID: 23606266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.